Access the full text.
Sign up today, get DeepDyve free for 14 days.
A Biggers, Y Shi, J Charlson, EC Smith, AJ Smallwood, AB Nattinger, PW Laud, JM Neuner (2016)
Medicare D subsidies and racial disparities in persistence and adherence with hormonal therapyJ Clin Oncol, 34
L London, A Hurtado-de-Mendoza, M Song, A Nagirimadugu, G Luta, VB Sheppard (2015)
Motivators and barriers to Latinas’ participation in clinical trials: the role of contextual factorsContemp Clin Trials, 40
VA Moyer (2014)
Risk assessment, genetic counseling, and genetic testing for BRCA-related breast cancer in women: U.S. preventive services task force recommendation statementAnn Intern Med, 160
JA Liedtke (1995)
Changing the organizational culture of technology education to attract minorities and womenTechnol Teach, 54
WR Carpenter, S Tyree, Y Wu (2012)
A surveillance system for monitoring, public reporting, and improving minority access to cancer clinical trialsClin Trials, 9
SM Kircher, CR Meeker, H Nimeiri (2016)
The parity paradigm: can legislation help reduce the cost burden of oral anticancer medications?Value Health, 19
A Nishi, DA Milner, EL Giovannucci (2016)
Integration of molecular pathology, epidemiology and social science for global precision medicineExpert Rev Mol Diagn, 16
KL Braun, S Stewart, C Bacquet (2015)
The national cancer institute’s community networks program initiative to reduce cancer health disparities: outcomes and lessons learnedProg Community Health Partnersh, 9
U Al-Alem, G Rauscher, E Shah (2014)
Association of genetic ancestry with breast cancer in ethnically diverse women from ChicagoPLoS ONE, 9
NA Ponce, M Ko, SY Liang (2015)
Early diffusion of gene expression profiling in breast cancer patients associated with areas of high income inequalityHealth Aff (Millwood)., 34
A Ramirez, I Thompson, L Vela (2013)
A health disparities roadmapSouth Tex Health Status Rev
M Dean, J Boland, M Yeager (2015)
Addressing health disparities in Hispanic breast cancer: accurate and inexpensive sequencing of BRCA1 and BRCA2GigaScience, 4
LBA Rangel, JL Taraba, CR Frei, L Smith, G Rodriguez, JG Kuhn (2014)
Pharmacogenomic diversity of tamoxifen metabolites and estrogen receptor genes in Hispanics and non-Hispanic whites with breast cancerBreast Cancer Res Treat, 148
TR Rebbeck (2006)
Conquering cancer disparities: new opportunities for cancer epidemiology, biomarker and prevention researchCancer Epidemiol Biomark Prev, 15
GL Anderson, WE Barrington (2016)
Narrowing of racial disparities in breast cancer incidence: insights from menopausal hormone therapy study findingsJ Natl Cancer Inst, 108
AE Connor, RN Baumgartner, KB Baumgartner (2015)
Associations between ALOX, COX, and CRP polymorphisms and breast cancer among Hispanic and non-Hispanic white women: the breast cancer health disparities studyMol Carcinog, 54
RL Siegel, KD Miller, A Goding-Sauer, PS Pinheiro, D Martinez-Tyson, A Jemal (2015)
Cancer statistics for Hispanics/Latinos, 2015CA Cancer J Clin, 65
SB Dusetzina, NL Keating (2016)
Mind the gap: why closing the doughnut hole is insufficient for increasing medicare beneficiary access to oral chemotherapyJ Clin Oncol, 34
TN Bethea, CM Kitahara, J Sonderman, AV Patel, C Harvey, SF Knutsen, Y Park, SY Park, GE Fraser, EJ Jacobs, MP Purdue, RZ Stolzenberg-Solomon, EM Gillanders, WJ Blot, JR Palmer, LN Kolonel (2014)
A pooled analysis of body mass index and pancreatic cancer mortality in African AmericansCancer Epidemiol Biomark Prev, 23
P Chalela, JA Pagan, D Su, E Munoz, A Ramirez (2012)
Breast cancer genetic testing awareness, attitudes and intentions of Latinas living along the U.S. Mexico border: a qualitative studyJ Community Med Health Educ, 2
JA Lee, CS Roehrig, Butto E Duggan (2016)
Cancer cost trends in the United States: 1998 to 2012Cancer, 122
K Kwiatkowski, K Coe, JC Bailar, GM Swanson (2013)
Inclusion of minorities and women in cancer clinical trials, a decade later: have we improved?Cancer, 119
NY Ko, JS Darnell, E Calhoun (2014)
Can patient navigation improve receipt of recommended breast cancer care? Evidence from the national patient navigation research programJ Clin Oncol, 32
JL Davis, R Ramos, V Rivera-Colon (2014)
The Yo me cuido program: addressing breast cancer screening and prevention among hispanic womenJ Cancer Educ, 30
In 1971, President Nixon signed into law the National Cancer Act (NCA), colloquially known as the “War on Cancer”, which pushed cancer onto the national agenda and is credited for many subsequent increases in the knowledge of the molecular, cellular, and genetic causes and effects of cancer. But even though cancer mortality has declined overall in intervening years after the NCA, cancer health disparities persist in the form of higher cancer incidence and mortality rates among certain cancer types and certain populations. Breast and cervical cancers disproportionately affect African American, Hispanic, and American Indian Women. Colorectal cancer is the second leading cause of death for Latinos (with men and women combined). Forty-five years after the NCA, how will the next enormous cancer initiatives—President Barack Obama’s Cancer Moonshot and the All of Us Research Program (formerly the Precision Medicine Initiative Cohort Program)—impact cancer health disparities? The emergence of precision medicine and the sharing of information across sectors are at the heart of these large national initiatives and hold vast potential to address complex health disparities that remain in incidence reporting, incidence, treatment, prognoses, and mortality among certain cancer types and racial/ethnic minorities, including African Americans and Hispanics/Latinos, compared to Whites. But clinical research efforts and data collection have historically lacked diverse representation for various reasons, posing a large risk to these national initiatives in their ability to develop diverse cohorts that adequately represent racial/ethnic minorities. Efforts to reduce disparities and increase diversity in study cohorts have emerged, from patient navigation, to use of mobile technology to collect data, to national consortiums dedicated to including diverse groups, to university training on health disparities. These efforts point to the need for the Cancer Moonshot and precision medicine leaders to develop a multifaceted approach to address disparities in health and healthcare to promote a diverse healthcare workforce, patient-centered care, maintenance of a database of information regarding the state of health disparities, and the institution of measurable goals for improving care across all ethnic groups. If these elements are included, it is possible that the Cancer Moonshot and precision medicine will benefit the entire population of our country.
Cancer Causes & Control – Springer Journals
Published: Aug 2, 2017
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.